The NIPT Trend

A number of companies now offer non-invasive prenatal tests that can, by isolating fetal DNA from the mother's bloodstream, determine if the fetus has a chromosomal disorder. And, as Fortune's Clay Dillow writes, those tests may soon be able to detect even more disorders. "[I]f parents could know more about their child's health before birth, wouldn't they want to?" he adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.